image
Acrivon Therapeutics, Inc. Common Stock ACRV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.96
-12.1 %
$ 216 M
Market Cap
-2.56
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -103.48% -105.89%
Annual Report FY 10-K 2022-12-31 0.00% -82.71% -101.79%
Annual Report FY 10-K 2021-12-31 0.00% -206.13% -410.86%
Annual Report FY 10-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -55.13% -55.79%
Quarterly Report Q2 8-K 2024-06-30 0.00% -35.10% -38.13%
Quarterly Report Q1 8-K 2024-03-31 0.00% -48.27% -22.75%
Quarterly Report Q4 8-K 2023-12-31 0.00% -143.30% -111.69%
Quarterly Report Q3 8-K 2023-09-30 0.00% -64.00% -68.53%
Quarterly Report Q2 8-K 2023-06-30 0.00% -143.46% -161.94%
Quarterly Report Q1 8-K 2023-03-31 0.00% -53.83% -99.57%
Quarterly Report Q4 8-K 2022-12-31 0.00% -79.19% -132.90%
Quarterly Report Q3 8-K 2022-09-30 0.00% -299.32% -258.48%
Quarterly Report Q2 8-K 2022-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2022-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2021-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2021-09-30 0.00% 0.00% 0.00%